Private company
Gero
Biotechnology company applying physics and artificial intelligence to aging research
Gero is a privately held biotechnology company that develops a drug discovery platform combining artificial intelligence with a physics-based theory of aging originated and published by its co-founder, the physicist Peter Fedichev. The platform identifies drug targets by analysing large-scale longitudinal human health data and distinguishing potentially reversible, disease-associated processes from the largely irreversible accumulation of damage associated with aging.2 Wikipedia text CC BY-SA 4.0
Last updated Oct 21, 2026.
Overview
See how the biggest companies compare on our leaderboards
Gero is a privately held biotechnology company that develops a drug discovery platform combining artificial intelligence with a physics-based theory of aging originated and published by its co-founder, the physicist Peter Fedichev. The platform identifies drug targets by analysing large-scale longitudinal human health data and distinguishing potentially reversible, disease-associated processes from the largely irreversible accumulation of damage associated with aging.2
Links
- WikipediaGero (company)
- WikidataQ138542717
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataGero on Wikidata
- 2WikipediaGero on Wikipedia